Having antiretrovirals on hand to take as post-exposure prophylaxis after potential HIV exposure, an approach known as PEP-in-pocket, or PIP, is a feasible prevention option, especially for people who ...
On National HIV Testing Day, getting tested remains a gateway to prevention and treatment, but improving access alone is not enough. Expanding access to PrEP, PEP, pharmacists, long-acting therapies, ...
Offering structured PrEP and PEP choices, including cabotegravir, could reduce HIV incidence by one-third over 10 years in Africa. The dynamic choice HIV prevention approach increased PrEP uptake from ...
MedPage Today on MSNOpinion
HIV will end with system redesign, not when we discover another drug
We need to make prevention accessible, treatment immediate, and long-term engagement effor ...
Please provide your email address to receive an email when new articles are posted on . Quarterly chlamydia positivity dropped from 9.6% before doxy-PEP initiation to 2% afterwards among users.
A Delaware bill mandating health insurance coverage for HIV prevention drugs PrEP and PEP has passed both the House and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results